Late-stage labeling of diverse peptides and proteins with iodine-125
Journal of Pharmaceutical Analysis · 2025-07 · 15 (7) · 101198
DOI: 10.1016/j.jpha.2025.101198 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2025-07. Verfasst von Aleš Marek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, 16610, Czech Republic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, European Commission, Akademie Věd České Republiky.
Abstract (Originalsprache)
The preparation of specifically iodine-125 (125I)-labeled peptides of high purity and specific activity represents a key tool for the detailed characterization of their binding properties in interaction with their binding partners. Early synthetic methods for the incorporation of iodine faced challenges such as harsh reaction conditions, the use of strong oxidants and low reproducibility. Herein, we review well-established radiolabeling strategies available to incorporate radionuclide into a protein of interest, and our long-term experience with a mild, simple and generally applicable technique of 125I late-stage-labeling of biomolecules using the Pierce iodination reagent for the direct solid-phase oxidation of radioactive iodide. General recommendations, tips, and details of optimized chromatographic conditions to isolate pure, specifically 125I-mono-labeled biomolecules are illustrated on a diverse series of (poly)peptides, ranging up to 7.6 kDa and 67 amino acids (aa). These series include peptides that contain at least one tyrosine or histidine residue, along with those featuring disulfide crosslinking or lipophilic derivatization. This mild and straightforward late-stage-labeling technique is easily applicable to longer and more sensitive proteins, as demonstrated in the cases of the insulin-like growth factor binding protein-3 (IGF-BP-3) (29 kDa and 264 aa) and the acid-labile subunit (ALS) (93 kDa and 578 aa).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, 16610, Czech Republic.
Förderung
- Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences
- European Commission
- Akademie Věd České Republiky
- Czech Science Foundation
Zitieren
APA
Marek, A., Brož, B., Kriegelstein, M., Nováková, G., Hojcsková, J., Blechová, M., Žáková, L., Jiráček, J., & Maletínská, L. (2025). Late-stage labeling of diverse peptides and proteins with iodine-125. Journal of Pharmaceutical Analysis, 15(7), 101198. https://doi.org/10.1016/j.jpha.2025.101198
Vancouver
Marek A, Brož B, Kriegelstein M, Nováková G, Hojcsková J, Blechová M, et al. Late-stage labeling of diverse peptides and proteins with iodine-125. Journal of Pharmaceutical Analysis. 2025;15(7):101198. doi:10.1016/j.jpha.2025.101198
BibTeX
@article{Marek2025,
author = {Marek, Aleš and Brož, Břetislav and Kriegelstein, Michal and Nováková, Gabriela and Hojcsková, Jana and Blechová, Miroslava and Žáková, Lenka and Jiráček, Jiří and Maletínská, Lenka},
title = {Late-stage labeling of diverse peptides and proteins with iodine-125},
journal = {Journal of Pharmaceutical Analysis},
year = {2025},
volume = {15},
number = {7},
pages = {101198},
doi = {10.1016/j.jpha.2025.101198}
}
EUVIMED